Sean Fullerton, M.D., specializes in Benign Prostatic Hyperplasia (BPH), obstructive uropathy, complex urinary stones, bladder dysfunction in men and women, kidney obstruction, and prostatitis. He supervises the resident clinic run weekly at Westchester Medical Center. In this respect, Dr. Fullerton ensures that residents build their own ‘patient panels’ and practice a continuity of care that will prove invaluable. He trains the residents in urodynamics, office cystoscopy, prostate biopsy, and ambulatory surgery.

Education

• M.D., State University of New York Medical University
• Residency, General Surgery, Lincoln Medical & Mental Health Center
• Residency, Urology, Westchester County Medical Center

Areas of Expertise

• Adult General Urology
• Endourology
• Benign prostatic hyperplasia (BPH)

Honors and Awards

• Top Doctor Award during Metropolitan Annual Medical Board Award Ceremony, 2016

Research

Dr. Fullerton serves as the P.I. of a prospective research study involving “Use of Thulium Laser in Urology”. This study will be conducted at WMC and MHC. Aside from Dr. Fullerton, Drs. Majid Eshghi at WMC and Dr. Sameh Naim at MHC will be involved in this prospective study. Dr. Fullerton will serve as Co-PI of two other studies (PCNL/Ureteroscopy) with Dr. Eshghi and Dr. Naim.

Publications

• Guerrini CJ, Robinson JO, Elsaid MI, et. al. "FIGG at 5: An update on U.S. public perspectives on forensic investigative genetic genealogy five years after its introduction to criminal investigations." Forensic science international, 367(), (2025) 112372. doi: 10.1016/j.forsciint.2025.112372
• Esquetini-Vernon C, Meschia JF, Huang J, et. al. "Higher Rate of Reinterventions After Transfemoral Carotid Artery Stenting in Symptomatic Patients: A Retrospective Stroke Center's Cohort Study between 2015-2024." Annals of vascular surgery, (), (2025) . pii: S0890-5096(25)00027-5. doi: 10.1016/j.avsg.2024.12.074
• Guccione L, Best S, Fullerton S, et. al. "Mapping provider and consumer voices using the AACTT framework: a focus group study of advance care planning." BMC health services research, 25(1), (2025) 115. doi: 10.1186/s12913-025-12240-8
• Guerrini CJ, Kalokairinou L, Robinson JO, et. al. "Investigative genetic genealogy practices warranting policy attention: Results of a modified policy Delphi." PLoS genetics, 21(1), (2025) e1011520. doi: 10.1371/journal.pgen.1011520
• Myers CT, Kumar RD, Pilgram L, et. al. "Genomic Data and Privacy." Clinical chemistry, 71(1), (2025) 10-17. doi: 10.1093/clinchem/hvae184
• Rao ND, Fullerton SM, Shirts BH, et. al. "Applying health equity implementation science frameworks to population genetic screening." Frontiers in health services, 4(), (2024) 1455365. doi: 10.3389/frhs.2024.1455365
• Kullo IJ, Conomos MP, Nelson SC, et. al. "The PRIMED Consortium: Reducing disparities in polygenic risk assessment." American journal of human genetics, 111(12), (2024) 2594-2606. doi: 10.1016/j.ajhg.2024.10.010

View All Publications

Memberships and Affiliations

• American Urological Association
• NYS, AUA
• Board of Advisers, Diversified Community Health Services, Inc.
• American Cancer Society
• Admissions Committee, NYMC
• CCC, Clinical Committee
• Surgical Performance Improvement Committee, MHC
• PEC, NYMC
• Annual Program Review Committee
• Resident Selection Committee

Teaching Responsibilities

As the Director of Ambulatory Care Urology at WMC, Dr. Fullerton provides outstanding teaching, mentoring, and supervisory services to all rotating medical students, residents, and fellows. In this weekly urology, clinic trainees have the opportunity of longitudinal follow-ups of patients. As a senior attending in the Department of Urology, he provides supervisory and teaching services to trainees in the in-patient setting at WMC.

Similarly at MHC, Dr. Fullerton provides excellent teaching, mentoring and supervisory services to medical students and residents. He is scheduled to give two talks at the Grand Rounds conference in this academic year.